The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
BMJ Oncology
(Aug 2024)
Recall of ibrutinib and issues with therapeutic approval
Alyson Haslam,
Colton Lipfert,
Myung Sun Kim,
Vinay K Prasad
Affiliations
Alyson Haslam
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
Colton Lipfert
Columbia University, Manhattan, New York, USA
Myung Sun Kim
Compass Oncology, Portland, Oregon, USA
Vinay K Prasad
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
DOI
https://doi.org/10.1136/bmjonc-2024-000418
Journal volume & issue
Vol. 3, no. 1
Abstract
Read online
No abstracts available.
WeChat QR code
Close